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Summary 
 
 A total of 320 weanling pigs (10.7 lb and 
14 ± 3 d of age, PIC) was used to determine 
the effects of antibiotics and an antibiotic al-
ternative on nursery pig performance.  Pigs 
were fed one of 5 experimental diets: 1) con-
trol with no antimicrobials; 2) carbadox (50 
g/ton); 3) Denagard/CTC (35 g/ton Dena-
gard™, 400 g/ton Chlortetracycline); 4) Neo-
Terramycin® (140 g/ton Neomycin Sulfate, 
140 g/ton Oxytetracycline HCl); 5) Bio Mos 
(0.3%, mannanoligosaccharide).  Overall (d 0 
to 31 post-weaning), pigs fed the diet contain-
ing Denagard/CTC had the greatest (P<0.05) 
ADG and ADFI compared to pigs fed all other 
treatment diets.  Pigs fed the diet containing 
Neo-Terramycin had greater (P<0.05) ADG 
compared to pigs fed the control diet or diets 
containing Carbadox or Bio Mos.  In addition, 
pigs fed the diet containing Neo-Terramycin 
had greater (P<0.05) ADFI compared to pigs 
fed the control diet or the diet containing Bio 
Mos.  In conclusion, the addition of carbadox 
and Bio Mos did not result in improved 
growth performance compared to pigs fed the 
control diet.  However, improvements were 
seen in average daily gain and daily feed in-
take with the addition of Denagard/CTC and 
Neo-Terramycin. Commercial operations need 
to determine which feed additives improve 
nursery pig performance in their individual 
production systems.  
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Introduction 
 
 The use of feed grade antibiotics in nurs-
ery pig diets has long been recognized as a 
method to improve growth performance and 
health.  Due to recent concerns with the use of 
subtherapeutic antibiotics, research is being 
conducted on different options.  Current re-
search at Kansas State University has looked 
at viable options with the use of yeasts, direct 
fed microbials and mannanoligosaccharides.  
Results from these trials have not shown 
growth performance benefits to antibiotic al-
ternatives.  Also, these same trials found in-
consistent responses to the continued use of 
certain antibiotics in a commercial setting.  
Therefore, the objective of this trial was to 
evaluate different antibiotics and antibiotic 
alternatives on nursery pig performance. 
 
Procedures 
 
 A total of 320 weanling pigs (10.7 lb and 
14 ± 3 d of age, PIC) were blocked by weight 
and allotted to one of five dietary treatments.  
         
 
1Appreciation is expressed to Eichman Brothers Farm (St. George, Kansas) for the use of pigs and facili-
ties. 
2Food Animal Health and Management Center. 
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There were eight pigs per pen and eight pens 
per treatment.  The trial was conducted in an 
environmentally controlled nursery facility on 
a commercial farm in northeast Kansas.  Each 
pen was 4 x 6 ft and contained one self-feeder 
and two nipple waterers to provide ad libitum 
access to feed and water.   
 
 All pigs were fed treatment diets from 
weaning to d 31.  There were five experimen-
tal diets, with a control diet with no antim-
icrobials, or the control diet with added: car-
badox (50 g/ton); Denagard/CTC (35 g/ton 
Denagard™, 400 g/ton Chlortetracycline); 
Neo-Terramycin® (140 g/ton Neomycin Sul-
fate, 140 g/ton Oxytetracycline HCl); Bio Mos 
(0.3% mannanoligosaccharide).  All products 
were added at the manufacturers’ recom-
mended inclusion rates.  Dietary treatments 
were fed in meal form (Table 1).  Segregated 
Early Wean (SEW) diets, which were fed 
based on a feed budget of one pound per pig, 
were formulated to contain 1.70% lysine, 
0.81% Ca, and 0.60% available phosphorus. 
Transition diets were fed following comple-
tion of SEW diet until d 9 post-weaning.  The 
transition diets were formulated to contain 
1.60% lysine, 0.92% Ca, and 0.59% available 
phosphorus.  Phase II diets (d 9 to 31 post-
weaning) were formulated to contain 1.51% 
lysine, 0.81% Ca, and 0.47% available phos-
phorus.  These diets were formulated to simi-
lar specifications that were fed at the commer-
cial operation.  Average daily gain (ADG), 
ADFI, and F/G were determined by weighing 
pigs and measuring feed disappearance on d 9, 
22, and 31 post-weaning.  
 
 Data were analyzed as a randomized com-
plete block design with pen as the experimen-
tal unit.  Pigs were blocked based on weaning 
weight, and analysis of variance was per-
formed using the MIXED procedure of SAS. 
 
Results and Discussion 
 
 From d 0 to 9, pigs fed the diet containing 
Denagard/CTC tended to have greater 
(P<0.10) ADG compared to pigs fed the con-
trol diet or pigs fed the diet containing Bio 
Mos.  
 
 From d 9 to 31 when pigs were fed phase 
two diets, pigs fed the diet containing Dena-
gard/CTC had the greatest (P<0.05) ADG and 
ADFI compared to pigs fed all other diets.  
Also, pigs fed the diet containing Neo-
Terramycin had greater (P<0.05) ADG and 
ADFI compared to pigs fed the control diet or 
diets containing carbadox or Bio Mos.  No 
difference in feed efficiency was observed 
from d 9 to 31. 
 
 Overall (d 0 to 31 post-weaning), pigs fed 
the diet containing Denagard/CTC had the 
greatest (P<0.05) ADG and ADFI compared 
to pigs fed all other treatment diets.  Pigs fed 
the diet containing Neo-Terramycin had 
greater (P<0.05) ADG compared to pigs fed 
the control diet or pigs fed diets containing 
carbadox or Bio Mos.  In addition, pigs fed the 
diet containing Neo-Terramycin had greater 
(P<0.05) ADFI compared to pigs fed the con-
trol diet and pigs fed the diet containing Bio 
Mos.  There was no difference in F/G between 
the dietary treatments. 
 
 As expected, no differences in pig weight 
variation were seen at the start of the trial due 
to allotment and randomization methods.  
However, pigs fed the diet containing Bio 
Mos tended to have greater (P<0.05) weight 
variation at trial completion (d 31) compared 
to pigs fed the control diet or diets containing 
Denagard/CTC or Neo-Terramycin.   
 
 In conclusion, similar to previous trials 
conducted at Kansas State University, the ad-
dition of a mannanoligosaccharide did not im-
prove growth performance.  Also, the use of 
Carbadox in this commercial operation did not 
improve growth performance, which agrees 
with previous research conducted in this facil-
ity.  However, improvement in growth per-
formance was seen in with the addition of De-
nagard/CTC and Neo-Terramycin. These data 
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confirm the importance of monitoring per-
formance when using antibiotics or antibiotic 
alternatives in determining which additives are 
the most effective in individual operations. 
Table 1.  Diet Composition (As-fed Basis) 
Item, % SEWa Transitionb Phase IIc 
Corn 40.26 41.22 50.75 
Soybean meal, 46.5% 12.09 21.56 27.68 
Spray died whey 25.00 25.00 10.00 
Spray-dried animal plasma 6.70 2.50 - 
Select menhaden fishmeal 6.00 6.00 4.50 
Lactose 5.00 - - 
Spray-dried blood meal 1.65 - - 
Soy oil -  - 3.00 
Test ingredient or starchd 1.00 1.00 1.00 
Monocalcium phosphate, 21% P 0.50 0.75 1.00 
Limestone 0.40 0.50 0.55 
Zinc oxide 0.38 0.38 0.25 
Salt 0.25 0.30 0.30 
Vitamin premix  0.25 0.25 0.25 
Lysine HCl 0.15 0.20 0.30 
DL-methionine 0.15 0.13 0.15 
Trace mineral premix 0.15 0.15 0.15 
L-threonine 0.08 0.08 0.13 
 100.00 100.00 100.00 
 
Calculated Analysis    
   Lysine, % 1.70 1.60 1.51 
   Isoleucine:lysine ratio, % 51 60 61 
   Leucine:lysine ratio, % 124 121 121 
   Methionine:lysine ratio, % 30 32 34 
   Met & cys:lysine ratio, % 56 57 58 
   Threonine:lysine ratio, % 66 66 64 
   Tryptophan:lysine ratio, % 18 18 17 
   Valine:lysine ratio, % 73 69 68 
   ME, kcal/lb 1,489 1,476 1,545 
   CP, % 22.59 22.28 21.22 
   Ca, % 0.81 0.92 0.81 
   P, % 0.78 0.83 0.75 
   Available P, % 0.60 0.59 0.47 
aOne pound fed per pig.  bDiets fed following SEW to d 9 post-weaning.  cDiets fed from d 9 to 
31 post-weaning.  dTest ingredients replaced cornstarch at the following inclusion rates: carba-
dox (50 g/ton); Denagard/CTC (35 g/ton Denagard™, 400 g/ton Chlortetracycline); Neo-
Terramycin® (140 g/ton Neomycin Sulfate, 140 g/ton Oxytetracycline HCl); Bio Mos (0.3% 
mannanoligosaccharide). 
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Table 2.  Effects of Antibiotics and an Antimicrobial Alternative on Growth Performance of Weanling Pigsa                                                 
  Feed Additivesb    
Item 
 
Control 
 
Carbadox 
Denagard/ 
CTC 
Neo- 
Terramycin
 
Bio Mos  
 
SE 
 
TRTc 
 D 0 to 9d        
    ADG, lb 0.31x 0.35xy 0.36y 0.35xy 0.30x 0.024 0.070 
    ADFI, lb 0.40 0.45 0.46 0.42 0.41 0.025 0.110 
    F/G 1.32 1.31 1.30 1.23 1.35 0.060 0.317 
 D 9 to 31e        
    ADG, lb 0.86f 0.87f 1.02h 0.95g 0.82f 0.031 0.001 
    ADFI, lb 1.17f 1.17f 1.38h 1.27g 1.11f 0.038 0.001 
    F/G 1.35 1.35 1.35 1.33 1.37 0.020 0.513 
 D 0 to 31        
    ADG, lb 0.70f 0.71f 0.83h 0.77g 0.67f 0.025 0.001 
    ADFI, lb 0.95f 0.96fg 1.11h 1.01g 0.91f 0.032 0.001 
    F/G 1.35 1.34 1.34 1.32 1.36  0.019 0.196 
CV, %        
    D 0 0.069 0.069 0.070 0.071 0.072 0.002 0.265 
    D 31 0.127y 0.141xy 0.126y 0.117y 0.169x 0.021 0.120 
aA total of 320 pigs initially 10.7 lb and 14 ± 3 d of age with eight pigs/ pen and eight pens/ treatment. 
bTest ingredients replaced cornstarch at the following inclusion rates: carbadox (50 g/ton);  Denagard/CTC (35 g/ton Denagard™, 400 
g/ton Chlortetracycline); Neo-Terramycin® (140 g/ton Neomycin Sulfate, 140 g/ton Oxytetracycline HCl); Bio Mos (0.3% mannano-
ligosaccharide). 
cP-value represents overall treatment means. 
dOne pound of SEW budgeted per pig with transition diet then fed until d 9 post-weaning. 
eFrom d 9 to 31 pigs fed phase two diet. 
fghMeans in the same row with different superscripts differ (P<0.05). 
xyMeans in the same row with different superscripts differ (P<0.10). 
 
